Health: Pioneering child cancer care
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.A two-year-old boy who needs a bone marrow transplant and chemotherapy that will leave him sterile, is to undergo pioneering treatment in the hope he will still be able to father children. The new technique, which could help thousands of other young boys with cancer, was given the go- ahead by the lawyers for the Human Embryology and Fertilisation Authority yesterday. They have ruled that Oscar von Memery can have the treatment without having to give the written consent normally required by law.
Doctors will remove testicular tissue cells from Oscar, who has a rare metabolic disorder, before his therapy starts. The cells will be frozen, to be re- injected after Oscar reaches puberty in the hope he will then be able to father children.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments